FDA.reportPublic FDA data

dasatinib 50 MG Oral Tablet [Sprycel]

RxCUI
643175
RxNorm name
dasatinib 50 MG Oral Tablet [Sprycel]
Display name
dasatinib 50 MG Oral Tablet [Sprycel]
Full name
dasatinib 50 MG Oral Tablet [Sprycel]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4764f37b-c9e6-4ede-bcc2-8a03b7c521dfSPRYCEL 50 MG Oral Tablet [PSN] · dasatinib 50 MG Oral Tablet [Sprycel] [SBD] · Sprycel 50 MG Oral Tablet [SY]347These highlights do not include all the information needed to use SPRYCEL ® safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) tablets, for oral use Initial U.S. Approval: 200620240731